Farms.com Home   News

Domestic Demand to Pressure U.S. Corn, Soy, Wheat Stocks as Exports Fade

By Mark Weinraub

Strong domestic demand will keep U.S. stockpiles of corn and soybeans near seven-year lows even after farmers harvest the crops they are currently seeding, the government said on Wednesday.

The stocks estimates were in line with market expectations but the report showed that the recent gains in ag commodities, highlighted by soybean futures’ rally to a nearly nine-year high this week, are likely to continue.

“You could make the argument that the market has been undervalued for the last several months,” said Joe Vaclavik, president of Standard Grain.

The U.S. Agriculture Department’s monthly World Agricultural Supply and Demand Estimates report also showed that rising demand from the feed sector will push wheat stockpiles to a seven-year low by June 2022 as livestock and poultry producers scramble to find cheaper proteins for their animals’ diets.

Exports were seen falling for corn, soy and wheat versus the prior crop year.

USDA projected that U.S. corn stocks would stand at 1.507 billion bushels by Sept. 1, 2022, up from 1.257 billion bushels expected on Sept. 1, 2021.

Soybean stocks in September 2022 were seen rising just 20 million bushels from 120 million bushels forecast for 2021, according to USDA’s monthly World Agricultural Supply and Demand Estimates report.

The report projected a 4.5% increases in corn usage by ethanol producers in 2021/22 as more of the corn-based fuel is needed for drivers returning to the roads as the COVID-19 pandemic eases. For soybeans, demand from crushers that process soybeans into soymeal for animal feed, was seen up 35 million bushels to 2.225 billion. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.